AR240804A2 - Un procedimiento para preparar diesteres asimetricos del acido 1,4-dihidro-2,6-dimetil-1-piridin-3, 5-dicarboxilico - Google Patents
Un procedimiento para preparar diesteres asimetricos del acido 1,4-dihidro-2,6-dimetil-1-piridin-3, 5-dicarboxilicoInfo
- Publication number
- AR240804A2 AR240804A2 AR29947585A AR29947585A AR240804A2 AR 240804 A2 AR240804 A2 AR 240804A2 AR 29947585 A AR29947585 A AR 29947585A AR 29947585 A AR29947585 A AR 29947585A AR 240804 A2 AR240804 A2 AR 240804A2
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- already defined
- compound
- dihydro
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Abstract
UN PROCEDIMIENTO PARA LA PREPARACION DE UN DIESTER ASIMETRICO DEL ACIDO 1,4-DIHIDRO-2,6-DIMETILPIRIDIN-3, 5-DICARBOXILICO, DONDE EL ESTER TIENE LA FORMULA (I), PH ES FENILO, AR ES 2-NITROENILO, 3-NITROFENILO, 2, 3-DICLOROFENILO O BENZOFURAZAN-4-ILO, A ES ALQUILENO, R ES ALQUILO, OPCIONALMENTE SUSTITUIDO CON ALCOXI, R1 ES H, HIDROXI O ALQUILO Y R2 ES HO, METILO; LAS FORMAS ESTEREOQUIMICAMENTE ISOMERICAS DEL MISMO O LAS SALES DE ADICION DE ACIDOS FARMACEUTICAMENTE ACEPTABLES DEL MISMO. SE HACE CONDENSAR UN COMPUESTO DE FORMULA (II) AR-CHO, AR YA DEFINIDO, CON UN COMPUESTO DE FORMULA (III): CH3COCH2COOA1, A1 ES LA FORMULA (IV), A, R1, R2 Y PH SON LOS YA DEFINIDOS O UN GRUPO DE FORMULA AX GENERAL, DONDE A YA DEFINIDA Y X ES UN HALOGENO; HACER REACCIONAR EL CONDENSADO OBTENIDO CON UN COMPUESTO DE FORMULA (V), DONDE R YA DEFINIDO PARA DAR UN COMPUESTO DE FORMULA (VI), DONDE A1, AR Y R YA DEFINIDOS Y SI A1 REPRESENTA UN GRUPO DE FORMULA AX CONVERTIRLO DESPUES EN UN GRUPO DE FORMULA (IV) HACIENDO REACCIONAR LOS COMPUESTOS (VI) OBTENIDOS CON COMPUESTOS DE 3,3-DIFENILPROPILAMINA DE FORMULA (VII): HR1N-CHR2-CH2CH(PH)2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848403866A GB8403866D0 (en) | 1984-02-14 | 1984-02-14 | Diphenylalkylaminoalkyl esters |
Publications (2)
Publication Number | Publication Date |
---|---|
AR240804A1 AR240804A1 (es) | 1991-02-28 |
AR240804A2 true AR240804A2 (es) | 1991-02-28 |
Family
ID=10556581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR299475A AR240804A1 (es) | 1984-02-14 | 1985-02-11 | Un procedimiento para preparar diesteres asimetricos del acido 1,4-dihidro-2,6-dimetil-1-piridin-3,5-dicarboxilico |
Country Status (29)
Country | Link |
---|---|
US (3) | US4705797A (es) |
EP (1) | EP0153016B1 (es) |
JP (1) | JPS60199874A (es) |
KR (1) | KR910005231B1 (es) |
AR (1) | AR240804A1 (es) |
AT (1) | ATE52772T1 (es) |
AU (1) | AU570534B2 (es) |
BR (1) | BR1101167A (es) |
CA (1) | CA1277666C (es) |
DE (2) | DE10199007I2 (es) |
DK (1) | DK160985C (es) |
DZ (1) | DZ748A1 (es) |
EG (1) | EG17772A (es) |
ES (1) | ES8602664A1 (es) |
FI (1) | FI83954C (es) |
GB (1) | GB8403866D0 (es) |
GR (1) | GR850363B (es) |
HU (1) | HU194171B (es) |
IE (1) | IE57715B1 (es) |
IL (1) | IL74238A (es) |
LU (1) | LU90069I2 (es) |
MX (1) | MX156874A (es) |
NL (1) | NL970025I2 (es) |
NO (2) | NO166123C (es) |
NZ (1) | NZ210866A (es) |
PH (1) | PH20725A (es) |
PT (1) | PT79963B (es) |
SG (1) | SG48590G (es) |
ZA (1) | ZA85656B (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU561213B2 (en) * | 1983-06-02 | 1987-04-30 | Teijin Limited | 1, 4-dihydropyridine derivative |
US4994476A (en) * | 1984-10-31 | 1991-02-19 | Bristol-Myers Company | Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties |
DE3677319D1 (de) * | 1985-10-22 | 1991-03-07 | Sanwa Kagaku Kenkyusho Co | Pharmazeutische 1,4-dihydropyridinderivate, ihre salze und herstellung. |
DE3633496A1 (de) * | 1986-10-02 | 1988-04-14 | Hoechst Ag | Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln |
JPH02149563A (ja) * | 1988-11-30 | 1990-06-08 | Nisshin Flour Milling Co Ltd | 2−ハロエトキシカルボニル基を含有する1,4−ジヒドロピリジン誘導体の製造法 |
US5696139A (en) * | 1995-05-12 | 1997-12-09 | Recordati S.A., Chemical And Pharmaceutical Company | Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure |
US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
IT1275532B (it) * | 1995-07-14 | 1997-08-07 | Recordati Chem Pharm | Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa |
IT1279529B1 (it) * | 1995-05-12 | 1997-12-16 | Recordati Chem Pharm | Procedimento di preparazione ed uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca |
IT1274480B (it) * | 1995-05-12 | 1997-07-17 | Recordati Chem Pharm | Procedimento migliorato per la preparazione della lercanidipina cloridrato |
US5851636A (en) * | 1995-12-29 | 1998-12-22 | Lantec Products, Inc. | Ceramic packing with channels for thermal and catalytic beds |
ITMI20011726A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
ITMI20011727A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi |
US6852737B2 (en) * | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
CN1681495B (zh) | 2002-08-19 | 2010-05-12 | 辉瑞产品公司 | 用于治疗过度增生性疾病的组合物 |
US20040147566A1 (en) * | 2002-10-16 | 2004-07-29 | Amedeo Leonardi | Lisinopril/lercanidipine combination therapy |
US20050101640A1 (en) * | 2002-10-16 | 2005-05-12 | Recordati Ireland Limited | Lisinopril/lercanidipine combination therapy |
WO2004106299A2 (en) | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives and their use as hmg-co inhibitors |
WO2005107374A2 (en) * | 2004-05-07 | 2005-11-17 | Sun Pharmaceutical Industries Limited | A process for the preparation of 1,4-dihydropyridine-3,5-dicarboxylic acid derivative |
BRPI0513866A (pt) * | 2004-07-26 | 2008-05-20 | Cotherix Inc | composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação |
TW200613275A (en) * | 2004-08-24 | 2006-05-01 | Recordati Ireland Ltd | Lercanidipine salts |
US20060134212A1 (en) * | 2004-09-02 | 2006-06-22 | Forest Laboratories, Inc. | Lercanidipine immediate release compositions |
US20060165788A1 (en) * | 2004-09-09 | 2006-07-27 | Wattanaporn Abramowitz | Lercanidipine pH dependent pulsatile release compositions |
US20060165789A1 (en) * | 2004-09-09 | 2006-07-27 | Forest Laboratories, Inc. | Lercanidipine modified release compositions |
KR100616276B1 (ko) * | 2004-09-21 | 2006-08-28 | 일동제약주식회사 | 2,엔-디메틸-엔-(3,3-디페닐프로필)-1-아미노-2-프로판올의제조방법 |
TW200616681A (en) * | 2004-10-05 | 2006-06-01 | Recordati Ireland Ltd | Lercanidipine capsules |
KR100651212B1 (ko) * | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
IL165525A0 (en) * | 2004-12-02 | 2006-01-15 | Motivan Ltd | Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions |
AR053023A1 (es) * | 2005-02-25 | 2007-04-18 | Recordati Ireland Ltd | Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen |
AR052918A1 (es) * | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
KR100638171B1 (ko) * | 2005-03-25 | 2006-10-26 | 건일제약 주식회사 | 2,n-디메틸-n-(3,3-디페닐프로필)-1-아미노-2-프로판올의제조방법 |
SI1891009T1 (sl) * | 2005-06-15 | 2010-02-26 | Hetero Drugs Ltd Hetero House | Nov postopek priprave lerkanidipina |
KR20080048065A (ko) | 2005-09-16 | 2008-05-30 | 그렌마크 파머수티칼스 엘티디. | 다형 형태의 염산 레르카니디핀 및 이것의 제조방법 |
WO2007054969A2 (en) * | 2005-09-21 | 2007-05-18 | Torrent Pharmaceuticals Limited | Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
EP2351569B1 (en) | 2005-10-26 | 2012-08-22 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
US7893050B2 (en) * | 2005-10-26 | 2011-02-22 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
KR101329112B1 (ko) | 2005-11-08 | 2013-11-14 | 랜박시 래보러터리스 리미티드 | (3r,5r)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법 |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
WO2007120135A1 (en) * | 2006-04-17 | 2007-10-25 | Forest Laboratories, Inc. | Lercanidipine immediate release composition |
ATE415389T1 (de) * | 2006-05-24 | 2008-12-15 | Cf Pharma Ltd | Verfahren zur herstellung von lercanipidin |
AU2007280407B2 (en) * | 2006-08-04 | 2012-09-27 | Recordati Ireland Limited | Process for preparing amorphous lercanidipine hydrochloride |
US20080175872A1 (en) * | 2006-09-28 | 2008-07-24 | Osmotica Corp. | Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid |
CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
US20110040097A1 (en) * | 2006-12-29 | 2011-02-17 | Dongwoo Syntech Co., Ltd | Process for preparing lercanidipine hydrochloride |
KR100848935B1 (ko) | 2007-05-16 | 2008-07-29 | 주식회사 대희화학 | 생체 촉매 효소를 이용한 광학 선택적 가수분해방법 |
EA027787B1 (ru) | 2010-06-23 | 2017-09-29 | Крка, Товарна Здравил, Д.Д., Ново Место | Пероральные лекарственные формы, содержащие лерканидипин и эналаприл и их фармацевтически приемлемые соли |
US8883844B2 (en) | 2010-09-24 | 2014-11-11 | Nitrogenix Inc. | Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions |
EP2444394A1 (en) | 2010-10-21 | 2012-04-25 | Alembic Pharmaceuticals Limited | Process for the preparation of amorphous form of lercanidipine HCI |
EA023996B1 (ru) | 2010-12-24 | 2016-08-31 | КРКА, д.д., НОВО МЕСТО | Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацевтически приемлемые соли совместно с органической кислотой |
WO2012123966A1 (en) | 2011-03-04 | 2012-09-20 | Arch Pharmalabs Limited | Process for the preparation of 4 -substituted -1, 4-dihydropyridines |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
CN113574055A (zh) | 2019-01-18 | 2021-10-29 | 阿斯利康(瑞典)有限公司 | Pcsk9抑制剂及其使用方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3985758A (en) * | 1973-02-20 | 1976-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives |
JPS5762257A (en) * | 1980-10-03 | 1982-04-15 | Yoshitomi Pharmaceut Ind Ltd | 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt |
NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
DE3269219D1 (en) * | 1981-11-17 | 1986-03-27 | Fisons Plc | Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals |
ATE50987T1 (de) * | 1982-05-10 | 1990-03-15 | Takeda Chemical Industries Ltd | Dihydropyridinderivate, deren herstellung und verwendung. |
AU561213B2 (en) * | 1983-06-02 | 1987-04-30 | Teijin Limited | 1, 4-dihydropyridine derivative |
NO854021L (no) * | 1984-10-26 | 1986-04-28 | Bayer Ag | 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav. |
GB8503424D0 (en) * | 1985-02-11 | 1985-03-13 | Ici Plc | Heterocyclic derivatives |
-
1984
- 1984-02-14 GB GB848403866A patent/GB8403866D0/en active Pending
-
1985
- 1985-01-17 NZ NZ210866A patent/NZ210866A/xx unknown
- 1985-01-21 EP EP85300384A patent/EP0153016B1/en not_active Expired - Lifetime
- 1985-01-21 DE DE2001199007 patent/DE10199007I2/de active Active
- 1985-01-21 AT AT85300384T patent/ATE52772T1/de active
- 1985-01-21 DE DE8585300384T patent/DE3577703D1/de not_active Expired - Lifetime
- 1985-01-28 ZA ZA85656A patent/ZA85656B/xx unknown
- 1985-02-04 IL IL74238A patent/IL74238A/xx not_active IP Right Cessation
- 1985-02-06 IE IE280/85A patent/IE57715B1/en not_active IP Right Cessation
- 1985-02-08 FI FI850535A patent/FI83954C/fi not_active IP Right Cessation
- 1985-02-11 EG EG83/85A patent/EG17772A/xx active
- 1985-02-11 GR GR850363A patent/GR850363B/el not_active IP Right Cessation
- 1985-02-11 CA CA000474009A patent/CA1277666C/en not_active Expired - Lifetime
- 1985-02-11 AR AR299475A patent/AR240804A1/es active
- 1985-02-12 NO NO850521A patent/NO166123C/no unknown
- 1985-02-12 DK DK063085A patent/DK160985C/da not_active IP Right Cessation
- 1985-02-12 MX MX204305A patent/MX156874A/es unknown
- 1985-02-13 DZ DZ850035A patent/DZ748A1/fr active
- 1985-02-13 ES ES540385A patent/ES8602664A1/es not_active Expired
- 1985-02-13 AU AU38689/85A patent/AU570534B2/en not_active Expired
- 1985-02-13 KR KR1019850000888A patent/KR910005231B1/ko not_active IP Right Cessation
- 1985-02-13 PT PT79963A patent/PT79963B/pt unknown
- 1985-02-14 US US06/701,672 patent/US4705797A/en not_active Expired - Lifetime
- 1985-02-14 HU HU85554A patent/HU194171B/hu unknown
- 1985-02-14 JP JP60027527A patent/JPS60199874A/ja active Granted
- 1985-02-14 PH PH31860A patent/PH20725A/en unknown
-
1987
- 1987-08-19 US US07/086,739 patent/US4772621A/en not_active Expired - Lifetime
-
1988
- 1988-06-28 US US07/212,472 patent/US4968832A/en not_active Expired - Lifetime
-
1990
- 1990-07-02 SG SG485/90A patent/SG48590G/en unknown
-
1997
- 1997-05-14 BR BR1101167-0A patent/BR1101167A/pt active IP Right Grant
- 1997-05-28 LU LU90069C patent/LU90069I2/fr unknown
- 1997-07-11 NL NL970025C patent/NL970025I2/nl unknown
-
2000
- 2000-10-17 NO NO2000011C patent/NO2000011I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR240804A2 (es) | Un procedimiento para preparar diesteres asimetricos del acido 1,4-dihidro-2,6-dimetil-1-piridin-3, 5-dicarboxilico | |
ATE65993T1 (de) | Chinolinverbindung. | |
MX9304399A (es) | Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados. | |
DE69033069T2 (de) | Prostaglandinanaloge | |
DE69014807D1 (de) | Alkylester der Rosinsäure. | |
DK96286A (da) | 6-amidino-2-naphthyl-4-amino-benzoat-derivater og farmaceutisk acceptable syreadditionssalte deraf | |
ES543154A0 (es) | Metodo de preparar un derivado de acido b-carbolin-3-carbo- xilico | |
FR2584713B1 (fr) | Nouveaux derives de l'indole carboxamide, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant | |
SE9300013L (sv) | Nytt förfarande och mellanprodukter för framställning av pro- läkemedel | |
DK552682A (da) | Fremgangsmaade til fremstilling af hydroxybenzylaminobenzener | |
ES509636A0 (es) | "procedimiento para preparar nuevos compuestos de aroilimidazol-2-onas". | |
ES541544A0 (es) | Un metodo de preparar bestatinas | |
EA200100522A1 (ru) | Способ получения 1-замещенных 5- или 3-гидроксипиразолов | |
DE68905406D1 (de) | Chinolin-verbindung. | |
DK122085A (da) | Mellemprodukter til fremstilling af prostaglandinanaloge | |
AU609377B2 (en) | New derivaties of 4-OH quinoline carboxylic acid substituted in position 2 by a possibly etherified or esterified dihydroxyl group, the process and intermediates for preparation, their application as medicaments and the compositions containing them | |
DE3677465D1 (de) | N-glykolylneuraminsaeurederivat. | |
ES2078370T3 (es) | Procedimiento para preparar compuestos de esteres de acidos 2-halogeno-3-hidroxi-3-fenilpropionicos. | |
ES2082220T3 (es) | Preparacion de acidos acil-aminometano-fosfonicos y de acidos acil-aminometil-fosfinicos. | |
SU1271860A1 (ru) | Способ получени 2- @ (3,6-диалкил-3,6-диметил-2-цианометил-5-цианометилиден-1,4-оксатиан-2-ил)-тио @ -бензоксазолов | |
FI851218L (fi) | Nya 1,4-dihydropyridinderivat. | |
AR240803A2 (es) | Procedimiento para la preparacion de esteres | |
AR240919A2 (es) | Procedimiento para la prepararacion de derivados del acido quinolin-car-boxilico. | |
KR950032074A (ko) | β-니트로엔아민 및 그의 중간체의 제조 방법 | |
YU45942B (sh) | Postupak za dobivanje hidrohlorida 2(n-benzil-n-metilamino)-etil-metil-1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-3,5-piridin-dikarbok sil |